openPR Logo
Press release

Orphan Drugs Market Global Market Growth, Size, Share, Demand, Segments, Regional Trends | Forecasts 2020 - 2026

01-14-2020 09:14 AM CET | Health & Medicine

Press release from: Fortune Business Insights Private Limited

Orphan Drugs Market

Orphan Drugs Market

The rising prevalence for chronic diseases is a major factor expected to drive the global orphan drugs market during the forecast period. Fortune Business Insights in a recent report, titled “Orphan Drugs Market Size, Share and Global Trend by Therapy Area (Oncology, Haematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy), Drug Type (Biologics, Non-Biologics), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales) and Geography Forecast till 2025” published the above information. In the base year i.e. 2017, the global market was accounted for US$ 125,016.1 Mn and is estimated to reach US$ 294,037.8 Mn by forecast year i.e. 2025. Furthermore, the global market is anticipated to exhibit a CAGR of 11.4 % throughout the forecast years.

The report covers:

• Global Orphan Drugs Market trends, with detailed analysis on consumer trends & manufacturer trends.
• Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
• Key areas of investments identifying market opportunities and challenges in forecast timeframe.
• Competitive analysis of the industry players along with the overview on strategic management.
• Comprehensive company profiles of the major industry players.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/orphan-drugs-market-100088

Leading Players operating in the Orphan Drugs Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Amgen Inc.
• Biogen
• Actelion Pharmaceuticals Ltd.
• Bayer AG.

Rising Awareness about the Rare Disorders to Give Tailwinds to the Market

“The demand for specific orphan drugs is likely to increase as patients are becoming aware about the prevalent rare diseseses,” stated a lead analyst at Fortune Business Insights. “As a result of this, demand for orphan drugs is expected to increase in hospital pharmacies across the world,” he added. Rising R&D investments for drug development is another factor encouraging growth in the global orphan drugs market. Governments across the globe are developing a framework for drug development and discovery. This is expected to give significant impetus to the market in the forecast years.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/orphan-drugs-market-100088

Oncology Segment to Exhibit Considerably High Demand for Orphan Drugs

The demand for oncology orphan drugs is increasing mainly on account of rising prevalence of cancer. Also, increasing number of FDA approvals for oncology orphan drugs is expected to drive the oncology therapy segment. Increased EU approvals are likely to pave way for the entry of novel orphan drugs during the forecast period. The oncology area is facing tremendous pressure as majority of patients are diagnosed with cancer every year. Moreover, different types of rare cancers have been discovered over the past few years, which calls for an immediate need to implement the administration of complex orphan drugs. Fortune Business Insights in the report predicts that this segment covered a share of 49.8% in the global orphan drugs market.

Detailed Table of Content:

• Introduction
o Research Scope
o Market Segmentation
o Research Methodology
o Definitions and Assumptions
• Executive Summary
• Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
o Market Trends
• Key Insights
o Prevalence of major orphan disease, by key countries
o Pipeline review for orphan drugs
o Technological Developments
o Healthcare spending for key countries – 2017
• Global Orphan Drugs Market Analysis, Insights and Forecast, 2014-2025
o Key Findings / Summary
o Market Analysis, Insights and Forecast – By Therapy Area
 Oncology
 Hematology
 Neurology
 Endocrinology
 Cardiovascular
 Respiratory
 Immunotherapy
 Others
o Market Analysis, Insights and Forecast – By Drug Type
 Biologics
 Non-Biologics
o Market Analysis, Insights and Forecast – By Distribution Channels
 Hospital Pharmacy
 Retail Pharmacy
 Online Sales
 Others
o Market Analysis, Insights and Forecast – By Geography
 North America
 Europe
 Asia Pacific
 Rest of the World

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/orphan-drugs-market-100088
Reasons to Purchase this Report:

• Comprehensive analysis of the Orphan Drugs Market growth drivers, obstacles, opportunities, and other related challenges.
• Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
• Identifies market restraints and boosters.
• Identifies all the possible segments present in the market to aid organizations in strategic business planning.

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Orphan Drugs Market Global Market Growth, Size, Share, Demand, Segments, Regional Trends | Forecasts 2020 - 2026 here

News-ID: 1895420 • Views:

More Releases from Fortune Business Insights Private Limited

Electro-Optical/Infrared Systems Market Will Witness A Demand Increase, Led By The Industry's Size And Key Players
Electro-Optical/Infrared Systems Market Will Witness A Demand Increase, Led By T …
The global electro-optical/infrared (EO/IR) systems market size is expected to reach USD 20.36 billion by 2026, exhibiting a CAGR of 5.84% during the forecast period. The growing necessity to improve target identification, assess threats, and monitoring in different weather conditions will spur opportunities for the market during the forecast period. The increasing application of EO/IR in fire control system, airborne homeland security, search and rescue, surveillance, and intelligence, surveillance, target
Cryogenic Equipment Market 2022 In-depth Research with Emerging Growth Trends, Regional Status of Top Key Players, and Industry Size Forecast to 2028
Cryogenic Equipment Market 2022 In-depth Research with Emerging Growth Trends, R …
This research study can be used by all participants in the Cryogenic Equipment Market as it covers all major and minor aspects of the current and future market competition. It can also prove very beneficial for stakeholders in view of the range of courses on offer and a detailed analysis of the expected growth strategies of the players in the coming years. According to the data by Ecotricity, crude oil
Natural Zeolites Market Trends, Top Key Players, Business Opportunities, Industry Share, Size Analysis by Forecast 2029
Natural Zeolites Market Trends, Top Key Players, Business Opportunities, Industr …
The global natural zeolites market size is expected to gain momentum owing to the rising demand from construction industry during the forecast period. This information is published by Fortune Business Insights™ in an upcoming report, titled, "Natural Zeolites Market, 2022-2029." They are aluminosilicate minerals with a microporous surface that allows them to absorb a wide range of cations, including water. They are mined using traditional open-pit mining processes and they
Lemon Oil Market Share, Demand, Top Players, Industry Size, Future Growth By 2029
Lemon Oil Market Share, Demand, Top Players, Industry Size, Future Growth By 202 …
The global lemon oil market size is expected to gain momentum owing to the rising demand in cosmetic & personal care during the forecast period. This information is published by Fortune Business Insights™ in an upcoming report, titled, "Lemon Oil Market, 2022-2029." Liquid sunshine is another name for lemon oil. It's a citrus essential oil with a fresh scent that comes from the citrus lemon plant. The oil is extracted

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug